We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$187M
AUM Growth
+$27.3M
Cap. Flow
+$18.8M
Cap. Flow %
10.04%
Top 10 Hldgs %
34.89%
Holding
157
New
19
Increased
35
Reduced
66
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 28.74%
2 Energy 8.15%
3 Consumer Staples 6.41%
4 Technology 6.23%
5 Financials 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLTR icon
151
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.69B
-3,600
Closed -$228K
MTSI icon
152
MACOM Technology Solutions
MTSI
$23.2B
-6,100
Closed -$272K
TEVA icon
153
Teva Pharmaceuticals
TEVA
$41.2B
-18,150
Closed -$319K
EEP
154
DELISTED
Enbridge Energy Partners
EEP
-14,700
Closed -$235K
MTSC
155
DELISTED
MTS Systems Corp
MTSC
-3,900
Closed -$208K

Similar funds

Fernwood Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Fernwood Investment Management held 157 positions worth $187M, up 17% from $160M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Fernwood Investment Management deployed $18.8M of net new capital in Q4 2017, opening 19 new positions and adding to 35 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 21,670 shares worth $5.83M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 33% a quarter earlier, followed by Energy and Consumer Staples.

On the sell side, the largest reduction was Global Blood Therapeutics, Inc., an estimated $2.2M trimmed.

  • Fernwood Investment Management's largest Q4 2017 buy was iShares Core S&P 500 ETF: 21,670 shares worth $5.83M.
  • Fernwood Investment Management added most to iShares Select Dividend ETF in Q4 2017, an estimated $2.14M increase.
  • Fernwood Investment Management's biggest Q4 2017 reduction was Global Blood Therapeutics, Inc., cutting an estimated $2.2M.
  • Fernwood Investment Management fully exited Teva Pharmaceuticals in Q4 2017, selling an estimated $319K.
  • Fernwood Investment Management's ten largest holdings make up 35% of its $187M portfolio in Q4 2017.
  • Fernwood Investment Management opened 19 new positions and closed 8 in Q4 2017.
  • Fernwood Investment Management's portfolio value rose 17% quarter-over-quarter to $187M.

Based on Fernwood Investment Management's 13F filing for Q4 2017, filed 5 Feb 2018.